GlassScriptPhysician profile
Magdalena Marcinek
NPI 1235519075
$26,431.05
in general payments reported to CMS, 2019-2025
8 companies · $849 in 2025
The $849 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,859 · 2021: $13K · 2022: $6,872 · 2024: $40.90 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $534 · Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $533.83 |
| Food and Beverage | $356.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $17,163.89 | 2020-2022 | |
| Arthrex, INC. | $5,888.80 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $1,474.97 | 2022 | |
| Stryker Corporation | $1,229.71 | 2022-2025 | Prostep |
| Paragon 28, INC. | $504.37 | 2025 | Portfolio |
| Orthofix Medical, INC. | $116.50 | 2025 | Physio-Stim |
| Kerecis Limited | $40.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magdalena Marcinek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.